Evidence map›Paper›PMID 40070638›Full record

ArticleCureus2025

Adolescent Attitudes Toward the Human Papillomavirus (HPV) Vaccine in Kocaeli, Turkiye.

Melisa Y Gundogdu, M Z Gezer, Zuhal Gundogdu

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Melisa Y GundogduResearch, Nesibe Aydin Kocaeli, Kocaeli, TUR.
M Z GezerFaculty of Medicine, Kocaeli University Hospital, Kocaeli, TUR.
Zuhal GundogduPediatrics, Kocaeli University, Kocaeli, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The adolescent human papillomavirus (HPV) vaccination rate is relatively high in developed countries and it is not widespread in Turkiye. This paper explores what factors influence the decision on the acceptance of the HPV vaccine by adolescents. Methods Data from 206 adolescents was gathered via a survey completed after consent from the parents and themselves between May 2022 and September 2022. The survey content was based on the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS), each question being based on a 5-point Likert scale, together with additional questions to discover demographic factors. The participants were also questioned about their level of knowledge of HPV and its source. At the end of the questionnaire, once the adolescents were briefed on HPV vaccination by a doctor, questions about immunization against HPV were again redirected. Results The age of 206 participants was between 12 and 26 years old, and it was found that the knowledge level about the HPV vaccine increases as the age gets older. The adolescents believe that HPV protects more from cervical cancer than genital warts. 8.7% (n=18) of adolescents thought that the HPV vaccine could have long-term adverse effects. 33.5% (n=69) of them stated that their families could not afford the vaccine. After they were given more knowledge, it was found that they were more willing to have HPV immunization. Conclusions It is important to realize that teenagers' opinions can shift significantly, particularly in the context of informed decision-making and the provision of government financial assistance to parents. The comprehension of teenagers' perspectives and the extent of their knowledge regarding HPV is of paramount importance, given the likelihood of it being influenced by their own acceptance of the vaccine.

Indexed as

adolescentsattitudesbeliefscancerhpvhuman papillomavirusvaccine

Identifiers

PMID40070638
PMCPMC11894851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.